Chenghao Fei et al. [67] suggested that CASR is capable of significantly improving blood stasis, myocardial infarction, and blood lipid levels, and regulating the PI3K/AKT/mTOR signaling pathway, in CHD rats. The gene discussed is CASR; the disease is coronary artery disorder.